title: Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection.
abstract: Elevated expression of inhibitory receptors on virus-specific T cells has been implicated as a mechanism by which viruses evade host immune surveillance. Blockade of these pathways during chronic infection leads to increased T cell function and improved immune control of viral replication. To explore the association between costimulatory receptors and HIV replication, we examined the expression of programmed death 1 (PD-1), CTLA-4, T cell Ig domain and mucin domain 3 (TIM-3), and CD28 on HIV-specific CD4(+) T cells from HIV-infected subjects. Greater than 30% of HIV-specific CD4(+) T cells from untreated subjects coexpressed PD-1, CTLA-4, and TIM-3, whereas <2% of CMV- or varicella-zoster virus-specific CD4(+) T cells expressed all three receptors. Coexpression of all three inhibitory receptors on HIV-specific CD4(+) T cells was more strongly correlated with viral load compared with the expression of each receptor individually. Suppression of HIV replication with antiretroviral therapy was associated with decreased expression of all three inhibitory receptors on HIV-specific CD4(+) T cells. Surprisingly, a high percentage of HIV-specific CD4(+) T cells that expressed inhibitory receptors also coexpressed CD28. In vitro blockade of PD-1 binding concurrent with stimulation through CD28 synergistically increased HIV-specific CD4(+) T cell proliferation to a greater extent than did either alone. These findings indicate that HIV-specific CD4(+) T cell responses during chronic infection are regulated by complex patterns of coexpressed inhibitory receptors and that the synergistic effect of inhibitory receptor blockade and stimulation of costimulatory receptors could be used for therapeutic augmentation of HIV-specific CD4(+) T cell function.
authors.affiliation: Division of Allergy and Clinical Immunology, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.
authors.forename: Afework
authors.initials: A
authors.lastname: Kassu
authors.forename: Roland A
authors.initials: RA
authors.lastname: Marcus
authors.forename: Michelle B
authors.initials: MB
authors.lastname: D'Souza
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Kelly-McKnight
authors.forename: Lucy
authors.initials: L
authors.lastname: Golden-Mason
authors.forename: Ramesh
authors.initials: R
authors.lastname: Akkina
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Fontenot
authors.forename: Cara C
authors.initials: CC
authors.lastname: Wilson
authors.forename: Brent E
authors.initials: BE
authors.lastname: Palmer
mesh_terms: D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism* / Q000821:virology; D002908:Chronic Disease; D015331:Cohort Studies; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000378:metabolism / Q000821:virology; D015497:HIV-1 / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D011948:Receptors, Antigen, T-Cell / Q000502:physiology*
chemical_list: D018984:Epitopes, T-Lymphocyte; D011948:Receptors, Antigen, T-Cell